| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VACCINE.2013.01.050 |
| P698 | PubMed publication ID | 23398932 |
| P2093 | author name string | M Singh | |
| D T O'Hagan | |||
| S Gallorini | |||
| G Palladino | |||
| P R Dormitzer | |||
| K J Hansen | |||
| S Kommareddy | |||
| A Bonificio | |||
| A S Determan | |||
| B C Baudner | |||
| D M Dohmeier | |||
| J R Sternjohn | |||
| K D Kroells | |||
| P2860 | cites work | Pig and guinea pig skin as surrogates for human in vitro penetration studies: a quantitative review | Q23909844 |
| Coated microneedles for transdermal delivery | Q27478300 | ||
| The economic impact of pandemic influenza in the United States: priorities for intervention. | Q30323010 | ||
| Haemagglutinin quantification and identification of influenza A&B strains propagated in PER.C6 cells: a novel RP-HPLC method. | Q30353035 | ||
| Emulsion-based adjuvants for influenza vaccines. | Q30375985 | ||
| Needle-free influenza vaccination. | Q30394326 | ||
| Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunity | Q30399285 | ||
| MF59 adjuvant: the best insurance against influenza strain diversity | Q30402018 | ||
| New technologies for influenza vaccines | Q30411859 | ||
| Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge | Q30487666 | ||
| Innate immune evasion strategies of influenza viruses | Q33646273 | ||
| Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity | Q33664783 | ||
| Stability kinetics of influenza vaccine coated onto microneedles during drying and storage. | Q34047875 | ||
| Dissolving polymer microneedle patches for influenza vaccination | Q34049972 | ||
| Serological memory and long-term protection to novel H1N1 influenza virus after skin vaccination | Q35129385 | ||
| Delivery of subunit influenza vaccine to skin with microneedles improves immunogenicity and long-lived protection | Q35885039 | ||
| Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine | Q35987793 | ||
| Stability of influenza vaccine coated onto microneedles | Q36650284 | ||
| Minimally invasive insulin delivery in subjects with type 1 diabetes using hollow microneedles | Q37426334 | ||
| A systematic review of intradermal influenza vaccines | Q37941965 | ||
| Dissolvable microneedle patches for the delivery of cell-culture-derived influenza vaccine antigens | Q43755100 | ||
| Influenza virus surveillance, vaccine strain selection, and manufacture | Q45358113 | ||
| Painless drug delivery through microneedle-based transdermal patches featuring active infusion | Q46707523 | ||
| Economic costs of influenza-related work absenteeism. | Q48029712 | ||
| Development of lidocaine-coated microneedle product for rapid, safe, and prolonged local analgesic action | Q48249216 | ||
| Targeted, Needle-Free Vaccinations in Skin using Multilayered, Densely-Packed Dissolving Microprojection Arrays | Q61609414 | ||
| Nanopatch targeted delivery of both antigen and adjuvant to skin synergistically drives enhanced antibody responses | Q64445619 | ||
| Microneedles in clinical practice--an exploratory study into the opinions of healthcare professionals and the public | Q83202710 | ||
| Preparation of highly concentrated influenza vaccine for use in novel delivery approaches | Q85884712 | ||
| P433 | issue | 34 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3435-3441 | |
| P577 | publication date | 2013-02-08 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Influenza subunit vaccine coated microneedle patches elicit comparable immune responses to intramuscular injection in guinea pigs | |
| P478 | volume | 31 |
| Q34055422 | A protective role of murine langerin⁺ cells in immune responses to cutaneous vaccination with microneedle patches |
| Q38630763 | Biomedical applications of microneedles in therapeutics: recent advancements and implications in drug delivery. |
| Q35219316 | Coating solid dispersions on microneedles via a molten dip-coating method: development and in vitro evaluation for transdermal delivery of a water-insoluble drug |
| Q30358895 | Cutaneous immunization: an evolving paradigm in influenza vaccines |
| Q46958597 | Cutaneous vaccination: antigen delivery into or onto the skin. |
| Q38818697 | Dry influenza vaccines: towards a stable, effective and convenient alternative to conventional parenteral influenza vaccination |
| Q40990921 | Fabrication of cell culture-derived influenza vaccine dissolvable microstructures and evaluation of immunogenicity in guinea pigs |
| Q92437518 | Immune response and reactogenicity of an unadjuvanted intradermally delivered human papillomavirus vaccine using a first generation Nanopatch™ in rhesus macaques: An exploratory, pre-clinical feasibility assessment |
| Q42156511 | Inactivated polio vaccination using a microneedle patch is immunogenic in the rhesus macaque. |
| Q41503775 | Insertion Process of Ceramic Nanoporous Microneedles by Means of a Novel Mechanical Applicator Design. |
| Q50890208 | Long-term stability of influenza vaccine in a dissolving microneedle patch. |
| Q94562443 | Measles and rubella microarray array patches to increase vaccination coverage and achieve measles and rubella elimination in Africa |
| Q41006286 | Microfabrication for Drug Delivery |
| Q38646712 | Microneedle patches for vaccination in developing countries. |
| Q90406756 | Microneedle-Mediated Vaccine Delivery to the Oral Mucosa |
| Q28085656 | Microneedle-based drug and vaccine delivery via nanoporous microneedle arrays |
| Q38297827 | Microneedles for drug delivery: trends and progress |
| Q38681048 | Microneedles for vaccine delivery: challenges and future perspectives. |
| Q55435929 | Mini-Review: Assessing the Potential Impact of Microneedle Technologies on Home Healthcare Applications. |
| Q52602778 | Noninvasive vaccination against infectious diseases. |
| Q50169459 | Polymeric microneedles for transdermal protein delivery |
| Q89805253 | Progress in Microneedle-Mediated Protein Delivery |
| Q47101549 | Skin immunization by microneedle patch overcomes statin-induced suppression of immune responses to influenza vaccine |
| Q38231247 | Skin immunization with influenza vaccines. |
| Q90389809 | The potential role of using vaccine patches to induce immunity: platform and pathways to innovation and commercialization |
| Q38229145 | The role of microneedles for drug and vaccine delivery. |
| Q38799509 | The success of microneedle-mediated vaccine delivery into skin. |
Search more.